Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13


Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms.

Gostner JM, Becker K, Kurz K, Fuchs D.

Front Psychiatry. 2015 Jul 14;6:97. doi: 10.3389/fpsyt.2015.00097. eCollection 2015. Review.


Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders.

Bryant VE, Whitehead NE, Burrell LE 2nd, Dotson VM, Cook RL, Malloy P, Devlin K, Cohen RA.

AIDS Behav. 2015 Aug;19(8):1430-7. doi: 10.1007/s10461-014-0970-1.


Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action.

Weber E, Blackstone K, Woods SP.

Neuropsychol Rev. 2013 Mar;23(1):81-98. doi: 10.1007/s11065-013-9225-6. Epub 2013 Feb 16. Review.


Brain transcriptome-wide screen for HIV-1 Nef protein interaction partners reveals various membrane-associated proteins.

Kammula EC, Mötter J, Gorgels A, Jonas E, Hoffmann S, Willbold D.

PLoS One. 2012;7(12):e51578. doi: 10.1371/journal.pone.0051578. Epub 2012 Dec 17.


Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy.

Kranick SM, Nath A.

Continuum (Minneap Minn). 2012 Dec;18(6 Infectious Disease):1319-37. doi: 10.1212/ Review.


Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance.

Martino M, Rocchi G, Escelsior A, Fornaro M.

Curr Neuropharmacol. 2012 Jun;10(2):97-123. doi: 10.2174/157015912800604542.


How much do antiretroviral drugs penetrate into the central nervous system?

Ene L, Duiculescu D, Ruta SM.

J Med Life. 2011 Nov 14;4(4):432-9. Epub 2011 Nov 24. Review.


A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV.

Tsai AC, Weiser SD, Petersen ML, Ragland K, Kushel MB, Bangsberg DR.

Arch Gen Psychiatry. 2010 Dec;67(12):1282-90. doi: 10.1001/archgenpsychiatry.2010.160.


Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.

Perry SW, Barbieri J, Tong N, Polesskaya O, Pudasaini S, Stout A, Lu R, Kiebala M, Maggirwar SB, Gelbard HA.

J Neurosci. 2010 Oct 20;30(42):14153-64. doi: 10.1523/JNEUROSCI.1042-10.2010.


Molecular pathology of neuro-AIDS (CNS-HIV).

Crews L, Patrick C, Achim CL, Everall IP, Masliah E.

Int J Mol Sci. 2009 Mar;10(3):1045-63. doi: 10.3390/ijms10031045. Epub 2009 Mar 11. Review.


Aging, neurocognition, and medication adherence in HIV infection.

Ettenhofer ML, Hinkin CH, Castellon SA, Durvasula R, Ullman J, Lam M, Myers H, Wright MJ, Foley J.

Am J Geriatr Psychiatry. 2009 Apr;17(4):281-90. doi: 10.1097/JGP.0b013e31819431bd.


HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.

Kaul M.

Curr Opin Neurol. 2009 Jun;22(3):315-20. doi: 10.1097/WCO.0b013e328329cf3c. Review.


Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.

Achim CL, Adame A, Dumaop W, Everall IP, Masliah E; Neurobehavioral Research Center.

J Neuroimmune Pharmacol. 2009 Jun;4(2):190-9. doi: 10.1007/s11481-009-9152-8. Epub 2009 Mar 17.

Supplemental Content

Support Center